Inogen (INGN) EPS (Weighted Average and Diluted) (2013 - 2026)
Inogen (INGN) reported EPS (Weighted Average and Diluted) of -$0.3 for Q1 2026, down 20.0% year-over-year from -$0.37 in Q1 2025, and down 11.11% on a QoQ basis from -$0.27 in Q4 2025.
Inogen (INGN) has 14 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.3 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) fell 20.0% year-over-year to -$0.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.92 (up 20.0% YoY) and the FY2025 annual result came in at -$0.86, up 43.42% from the prior year.
- EPS (Weighted Average and Diluted) retreated to -$0.3 in Q1 2026 per INGN's latest filing, from -$0.27 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.15 in Q2 2022 and bottomed at -$2.48 in Q4 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.41 (2024), against an average of -$0.63.
- The widest annual swing landed in 2022, when EPS (Weighted Average and Diluted) sank 1966.67%; it then soared 87.31% in 2024.
- Tracing INGN's EPS (Weighted Average and Diluted) over 5 years: stood at -$2.48 in 2022, then soared by 54.03% to -$1.14 in 2023, then soared by 64.04% to -$0.41 in 2024, then jumped by 34.15% to -$0.27 in 2025, then dropped by 11.11% to -$0.3 in 2026.
- Per Business Quant, the three latest INGN EPS (Weighted Average and Diluted) figures stand at -$0.3 (Q1 2026), -$0.27 (Q4 2025), and -$0.2 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.20 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.25 |
| Dec 31, 2024 | -0.41 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.24 |
| Mar 31, 2024 | -0.62 |
| Dec 31, 2023 | -1.14 |
| Sep 30, 2023 | -1.97 |
| Jun 30, 2023 | -0.42 |
| Mar 31, 2023 | -0.88 |
| Dec 31, 2022 | -2.48 |
| Sep 30, 2022 | -0.42 |
| Jun 30, 2022 | -0.15 |
| Mar 31, 2022 | -0.62 |
| Dec 31, 2021 | -1.01 |
| Sep 30, 2021 | 0.53 |
| Jun 30, 2021 | 0.22 |
| Mar 31, 2021 | -0.03 |
| Dec 31, 2020 | -0.23 |
| Sep 30, 2020 | -0.08 |
| Jun 30, 2020 | 0.12 |
| Mar 31, 2020 | -0.07 |
| Dec 31, 2019 | -0.06 |
| Sep 30, 2019 | 0.31 |
| Jun 30, 2019 | 0.45 |
| Mar 31, 2019 | 0.24 |
| Dec 31, 2018 | 0.44 |
| Sep 30, 2018 | 0.73 |
| Jun 30, 2018 | 0.65 |
| Mar 31, 2018 | 0.48 |
| Dec 31, 2017 | -0.03 |
| Sep 30, 2017 | 0.33 |
| Jun 30, 2017 | 0.38 |
| Mar 31, 2017 | 0.27 |
| Dec 31, 2016 | 0.25 |
| Sep 30, 2016 | 0.25 |
| Jun 30, 2016 | 0.36 |
| Mar 31, 2016 | 0.12 |
| Dec 31, 2015 | 0.19 |
| Sep 30, 2015 | 0.13 |
| Jun 30, 2015 | 0.17 |
| Mar 31, 2015 | 0.08 |
| Dec 31, 2014 | 0.07 |
| Sep 30, 2014 | 0.11 |
| Jun 30, 2014 | 0.11 |
| Mar 31, 2014 | -0.01 |
| Dec 31, 2013 | 0.79 |
| Sep 30, 2013 | -3.90 |
| Jun 30, 2013 | 0.67 |
| Mar 31, 2013 | -3.65 |